Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.
By S. Chari, T. Smyrk, M. Levy, M. Topazian, N. Takahashi, Lizhi Zhang, J. Clain, R. Pearson, B. Petersen, S. Vege and 1 more. Clinical Gastroenterology and Hepatology, 2006
1,008 citations recorded by the source corpus.
Subfields: Epidemiology, Rheumatology, Surgery
View Paper: https://www.semanticscholar.org/paper/cf131f1ad16e1552171371e2ca21b11dcca85d45
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- K. Okazaki
- T. Kamisawa
- T. Shimosegawa
- Tetsuhide Ito
- H. Watanabe
- Fumihiro Okumura
- H. Hamano
- A. Kanno
Citations in the corpus
- Standard steroid treatment for autoimmune pancreatitis (2009, background): “In the analysis of 563 patients with AIP, 82% received oral steroid treatment. The remission rate of patients with AIP was significantly higher in those who received steroid treatment (98%) than in those who did not receive steroid treatment (74%). The relapse rate was significantly lower in patient”